Corporate R&D StrategyNVIDIA's BioNeMo Becomes Pharma's AI Backbone as Novo Nordisk Offloads Parkinson's Risk to AI PartnerSalvado•Jun 27, 2026
Pharma FinanceNovo Nordisk Licenses Parkinson's Program and Exits Cell Therapy as AI Reshapes Pharma R&DSalvado•May 16, 2026
